MT

Moshe Talpaz

University Of Texas System: 6 patents #431 of 6,559Top 7%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
University of Michigan: 2 patents #1,079 of 4,352Top 25%
US University Of Texas System: 1 patents #51 of 217Top 25%
📍 Ann Arbor, MI: #1,006 of 6,071 inventorsTop 20%
🗺 Michigan: #10,567 of 86,293 inventorsTop 15%
Overall (All Time): #566,946 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9868736 Deubiquitinase inhibitors and methods for use of the same Nicholas J. Donato, Luke Peterson, Matthew Young, Hollis D. Showalter, Christiane Wobus +2 more 2018-01-16
9096499 Compounds for treatment of cell proliferative diseases Waldemar Priebe, Nicholas J. Donato, Slawomir Szymanski, Izabela Fokt, Alexander Levitzki 2015-08-04
8809377 Deubiquitinase inhibitors and methods for use of the same Nicholas J. Donato, Christiane Wobus, Hollis D. Showalter, Jeffrey Perry, Roderick J. Sorenson +2 more 2014-08-19
8648102 Compounds for treatment of cell proliferative diseases Waldemar Priebe, Nicholas J. Donato, Slawomir Szymanski, Izabela Fokt, Alexander Levitzki 2014-02-11
8268837 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Nicholas J. Donato, Doriano Fabbro, Paul W. Manley, Jurgen Mestan, Markus Warmuth +2 more 2012-09-18
8119649 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Nicholas J. Donato, Doriano Fabbro, Paul W. Manley, Jurgen Mestan, Markus Warmuth +2 more 2012-02-21
8119827 Compounds for treatment of cell proliferative diseases Waldemar Priebe, Nicholas J. Donato, Slawomir Szymanski, Izabela Fokt, Alexander Levitzki 2012-02-21
7745468 Compounds for treatment of cell proliferative diseases Waldemar Priebe, Nicholas J. Donato, Slawomir Szymanski, Izabela Fokt, Alexander Levitzki 2010-06-29
7468379 Inhibition of osteolytic lesions by SRC kinase inhibitors Bryant G. Darnay, Janet E. Price, Ann Poblenz 2008-12-23